We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

SEP 28 2017

J&J Argues That Pfizer is Whining About Competing With Remicade - STAT News

Linda Pissott Reig, Shareholder in the firm's FDA & Biotechnology practice, comments on Pfizer Inc.'s suit alleging Johnson & Johnson stopped a biosimilar, a lower-priced version of an expensive drug. The lawsuit is the first of its kind. Read "J&J Argues That Pfizer is Whining About Competing With Remicade" in STAT News.